Logo image of OTC.CA

OCUMETICS TECHNOLOGY CORP (OTC.CA) Stock Fundamental Analysis

Canada - TSX Venture Exchange - TSX-V:OTC - CA67577H1047 - Common Stock

0.61 CAD
0 (0%)
Last: 1/23/2026, 7:00:00 PM
Fundamental Rating

0

OTC gets a fundamental rating of 0 out of 10. The analysis compared the fundamentals against 18 industry peers in the Health Care Equipment & Supplies industry. OTC may be in some trouble as it scores bad on both profitability and health. OTC does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • OTC had negative earnings in the past year.
  • OTC had a negative operating cash flow in the past year.
OTC.CA Yearly Net Income VS EBIT VS OCF VS FCFOTC.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 -1M -2M -3M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -259.88%, OTC is in line with its industry, outperforming 50.00% of the companies in the same industry.
Industry RankSector Rank
ROA -259.88%
ROE N/A
ROIC N/A
ROA(3y)-214.41%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
OTC.CA Yearly ROA, ROE, ROICOTC.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 -1K -2K -3K

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for OTC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
OTC.CA Yearly Profit, Operating, Gross MarginsOTC.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024

1

2. Health

2.1 Basic Checks

  • The number of shares outstanding for OTC has been increased compared to 1 year ago.
  • The debt/assets ratio for OTC is higher compared to a year ago.
OTC.CA Yearly Shares OutstandingOTC.CA Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 20M 40M 60M 80M 100M
OTC.CA Yearly Total Debt VS Total AssetsOTC.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 1M 2M 3M

2.2 Solvency

  • OTC has an Altman-Z score of -13.79. This is a bad value and indicates that OTC is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -13.79, OTC is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -13.79
ROIC/WACCN/A
WACCN/A
OTC.CA Yearly LT Debt VS Equity VS FCFOTC.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 2M -2M

2.3 Liquidity

  • OTC has a Current Ratio of 0.19. This is a bad value and indicates that OTC is not financially healthy enough and could expect problems in meeting its short term obligations.
  • OTC has a Current ratio of 0.19. This is comparable to the rest of the industry: OTC outperforms 44.44% of its industry peers.
  • A Quick Ratio of 0.19 indicates that OTC may have some problems paying its short term obligations.
  • OTC has a Quick ratio (0.19) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 0.19
Quick Ratio 0.19
OTC.CA Yearly Current Assets VS Current LiabilitesOTC.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 500K 1M 1.5M

0

3. Growth

3.1 Past

  • OTC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -45.45%.
EPS 1Y (TTM)-45.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-65.62%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for OTC. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OTC.CA Price Earnings VS Forward Price EarningsOTC.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OTC.CA Per share dataOTC.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0 0 0 0

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

  • No dividends for OTC!.
Industry RankSector Rank
Dividend Yield 0%

OCUMETICS TECHNOLOGY CORP / OTC.CA FAQ

What is the ChartMill fundamental rating of OCUMETICS TECHNOLOGY CORP (OTC.CA) stock?

ChartMill assigns a fundamental rating of 0 / 10 to OTC.CA.


Can you provide the valuation status for OCUMETICS TECHNOLOGY CORP?

ChartMill assigns a valuation rating of 0 / 10 to OCUMETICS TECHNOLOGY CORP (OTC.CA). This can be considered as Overvalued.


What is the profitability of OTC stock?

OCUMETICS TECHNOLOGY CORP (OTC.CA) has a profitability rating of 0 / 10.